59.40
price up icon5.86%   3.29
after-market アフターアワーズ: 59.50 0.10 +0.17%
loading
前日終値:
$56.11
開ける:
$56.04
24時間の取引高:
2.80M
Relative Volume:
1.16
時価総額:
$10.99B
収益:
$2.69B
当期純損益:
$-214.04M
株価収益率:
-37.46
EPS:
-1.5857
ネットキャッシュフロー:
$98.43M
1週間 パフォーマンス:
-3.02%
1か月 パフォーマンス:
+12.71%
6か月 パフォーマンス:
+35.00%
1年 パフォーマンス:
-11.74%
1日の値動き範囲:
Value
$55.98
$59.70
1週間の範囲:
Value
$55.65
$62.15
52週間の値動き範囲:
Value
$40.62
$79.62

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1176)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
6,600
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

EXAS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
59.40 10.99B 2.69B -214.04M 98.43M -1.17
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.05 200.45B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
228.55 165.08B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
134.51 38.36B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
197.27 35.80B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
412.26 33.76B 3.84B 866.24M 792.60M 10.37

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
Dec 16, 2024

Tidal Investments LLC Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Toronto Dominion Bank - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $72.00 at Bank of America - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Exact Sciences Co. (NASDAQ:EXAS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 14, 2024
pulisher
Dec 10, 2024

Groupama Asset Managment Acquires Shares of 1,204,952 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Exact Sciences Corp reports results for the quarter ended in September 30Earnings Summary - XM

Dec 09, 2024
pulisher
Dec 09, 2024

AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates - Yahoo Finance

Dec 09, 2024
pulisher
Dec 08, 2024

Pier Capital LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Soros Fund Management LLC Boosts Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Lil Jon Remixes Iconic ‘Get Low’ Hit To Promote Colon Cancer Screenings - Black Enterprise

Dec 06, 2024
pulisher
Dec 05, 2024

Polar Asset Management Partners Inc. Acquires 45,800 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Cerity Partners LLC - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Exact Sciences Corp (EXAS) Shares Up 4.18% on Dec 4 - GuruFocus.com

Dec 04, 2024
pulisher
Dec 04, 2024

CFRA raises Exact Sciences to buy, target to $72 from $48 - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Cinctive Capital Management LP Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

The Manufacturers Life Insurance Company Acquires 35,927 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Beacon Investment Advisory Services Inc. Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Exact Sciences and Lil Jon Partner on Get Low #2 Campaign to Encourage Colon Cancer Screening - El Diario NY

Dec 02, 2024
pulisher
Dec 02, 2024

Lil Jon partners with Exact Sciences to raise awareness for colorectal cancer screening - The Atlanta Voice

Dec 02, 2024
pulisher
Dec 02, 2024

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening - Mid Florida Newspapers

Dec 02, 2024
pulisher
Dec 02, 2024

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

30,536 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Fred Alger Management LLC - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

392,139 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Erste Asset Management GmbH - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Bellevue Group AG Grows Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Wasatch Advisors LP Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Braidwell LP - MarketBeat

Nov 30, 2024
pulisher
Nov 30, 2024

Northwest & Ethical Investments L.P. Sells 36,242 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Spyglass Capital Management LLC Has $95.17 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Fisher Asset Management LLC Sells 36,302 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Nov 29, 2024
pulisher
Nov 28, 2024

EXASExact Sciences Corp Latest Stock News & Market Updates - StockTitan

Nov 28, 2024
pulisher
Nov 27, 2024

Soros Capital Management LLC Acquires Shares of 51,700 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Exact Sciences stock lifted by TD Cowen, sees 10% revenue growth potential from CG+ - Investing.com Canada

Nov 26, 2024
pulisher
Nov 26, 2024

Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 26, 2024
pulisher
Nov 26, 2024

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) - AOL

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences stock outlook improves with Cologuard Plus launch and Medicare reimbursement - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences stock rating maintained outperform as Medicare pricing boosts CG+ outlook - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences stock up 10%, BTIG raises target after 16% price increase for Cologuard Plus - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences shares keep outperform rating on Medicare fee schedule boost - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

S&P 500 Futures Climb in Premarket Trading; Woodward, Exact Sciences Lead - Barron's

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences to Participate in December 2024 Investor Conferences - BioSpace

Nov 26, 2024
pulisher
Nov 26, 2024

Exact Sciences to Participate in December Investor Conferences - Business Wire

Nov 26, 2024
pulisher
Nov 25, 2024

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024 - El Diario NY

Nov 25, 2024
pulisher
Nov 25, 2024

Exact Sciences to present 10 abstracts on Precision Oncology portfolio at SABCS - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

Exact Sciences Advances Breast Cancer Care with the Oncotype DX - Business Wire

Nov 25, 2024
pulisher
Nov 25, 2024

Exact Sciences to Present 10 Key Studies on Breast Cancer Test Effectiveness at SABCS - StockTitan

Nov 25, 2024
pulisher
Nov 24, 2024

Exact Sciences Co. (NASDAQ:EXAS) Position Trimmed by Victory Capital Management Inc. - MarketBeat

Nov 24, 2024
pulisher
Nov 22, 2024

B. Metzler seel. Sohn & Co. Holding AG Buys Shares of 32,194 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Exact Sciences data show multi-biomarker class approach improves MCED cancer detection - The Cancer Letter

Nov 22, 2024
pulisher
Nov 21, 2024

Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com India

Nov 21, 2024

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Exact Sciences Corp (EXAS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Baranick Brian
EVP, GM, Precision Oncology
Oct 08 '24
Sale
70.00
929
65,030
12,758
diagnostics_research LH
$228.61
price up icon 0.72%
$161.88
price up icon 2.40%
$136.02
price up icon 1.51%
diagnostics_research WAT
$368.16
price up icon 2.09%
diagnostics_research MTD
$1,230.74
price up icon 2.05%
$412.26
price up icon 0.79%
大文字化:     |  ボリューム (24 時間):